Beyond Air CEO Steps Down; Commercial Chief Takes Over

  • Steve Lisi resigns as CEO of Beyond Air, effective March 27, 2026, to pursue other opportunities.
  • Robert Goodman, current Chief Commercial Officer, appointed as new CEO.
  • Goodman joined Beyond Air’s board in June 2025 and became CCO in November 2025.
  • Goodman has a track record in healthcare leadership at companies like BioTelemetry and Philips Healthcare.

Beyond Air’s leadership change comes as the company seeks to expand the market adoption of its LungFit PH system, a medical device for treating respiratory illnesses. Goodman’s appointment signals a focus on commercial scaling, aligning with broader industry trends toward operational efficiency and global market penetration in the medical technology sector. The transition underscores the strategic importance of leveraging experienced leadership to navigate rapid growth and competitive healthcare markets.

Commercial Execution
How Goodman’s commercial expertise will accelerate LungFit PH adoption in U.S. and international markets.
Market Expansion
Whether Beyond Air can scale operations to meet the demands of broader customer deployment.
Leadership Transition
The pace at which Goodman can integrate his strategy and drive sustainable growth.